iShares Short-Term California Muni Active ETF CALI 深 滬
等待開盤 11-26 09:30:00 美东时间
50.565
+0.005
+0.01%
華盛通- 最 高50.57
- 今 開50.555
- 成交量 5.53万股
- 最 低 50.548
- 昨 收 50.56
- 總市值 1.11亿
- 52周最高 50.60
- 市盈率 靜 --
- 換手率 2.52%
- 52周最低 48.8031
- 委 比 98.90%
- 總股本 220.00万
- 歷史最高 50.57
- 量 比 1.45
- 振 幅 0.04%
- 歷史最低 -3.1808
- 每 手 1
- 風險率 0.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PENSKE AUTOMOTIVE GROUP INCREASES PRESENCE IN CALIFORNIA AND TEXAS
Acquires Two Toyota and Two Lexus Dealerships, including Longo Toyota, the Largest Toyota Dealership in the U.S. Acquired Dealerships Expected to Add $1.5 Billion in Estimated Annualized Rev...
11-19 19:57
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Calidi Biotherapeutics reported third quarter 2025 results, highlighting new preclinical data on CLD-401 demonstrating immune protection and tumor-specific delivery via their RedTail platform. They established a Scientific Advisory Board with leading experts to support CLD-401 development and expanded RedTail's capabilities with programmable membranes and additional payloads. The company raised $6.9 million through an underwritten public offering...
11-13 21:15
涉及金额10亿元！100亿算力租赁概念股签订算力综合服务框架协议|盘后公告集锦
登录新浪财经APP 搜索【信披】查看更多考评等级 今日聚焦 【中贝通信：与弘信电子签订10亿元算力综合服务框架协议】 中贝通信(60...
11-10 20:09
Earnings Preview For Bruker
Bruker (NASDAQ:BRKR) is gearing up to announce its quarterly earnings on Monday...
11-01 00:02
BridgeBio Pharma Reports Positive Phase 3 Study Results
The latest announcement is out from BridgeBio Pharma ( ($BBIO) ). BridgeBio Pha...
10-30 04:40
BridgeBio's Investigation Drug Outperforms Standard Therapy In Rare Calcium Disorder
BridgeBio's Encaleret met its Phase 3 endpoint in ADH1, with 76% achieving calcium targets, supporting plans for FDA and EMA submissions in 2026.
10-30 02:22
Protagonist Therapeutics Announces New Data From Two Studies Of Icotrokinra, Investigational Targeted Oral Peptide That Precisely Blocks IL-23 Receptor
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement
10-27 19:41
乔布斯将登上美国创新1美元硬币
（来源：i商周） 当地时间10月15日，美国铸币局公布了2026年“美国创新1美元硬币”的设计方案。苹果公司联合创始人史蒂夫·乔布斯将出现在明年美国创...
10-17 15:48
Ainos Collaborates With NEXCOM International To Integrate Ainos' AI Nose Technology With NEXCOM's Industrial Edge Computing Platforms
SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a leader in AI-powered scent digitization, today announced a strategic partnership with NEXCOM International Co.,
10-14 20:33
世界标准日｜佛山照明以标准为基，共促可持续发展
2025年10月14日是第56个世界标准日，今年世界标准日的中国主题为“美好世界的共同愿景：增强伙伴关系，共促可持续发展”，旨在通过全球协作与标准化手段，推动经...
10-14 18:57
